MFC, CA56501R1064

Manulife stock joins UBS in Japan private-equity programme

Published on 11/13/2026 at 14:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Manulife stock is tied to a new Japan private-equity programme with UBS for wealth-management clients. Financial terms remain undisclosed.

Japan private equity partnership

  • Manulife Investment Management and UBS are developing a customized Japan private-equity co-investment programme for wealth-management clients.
  • Manulife contributes regional private-equity experience, sponsor relationships and underwriting capabilities.
  • UBS highlights business successions, corporate carve-outs and take-private transactions as potential sources of Japanese deal flow.
MFC, CA56501R1064, Illustration mit AI erstellt.

Manulife Investment Management and UBS announced on Tuesday, November 10, 2026, that they will collaborate on a customized Japan private-equity co-investment programme for wealth-management clients. The announcement was issued by Manulife Investment Management through PR Newswire.

Two platforms target Japanese deals

The programme combines Manulife Investment Management's regional private-equity experience, sponsor relationships and underwriting capabilities with UBS Unified Global Alternatives' expertise, global scale and distribution network. The partners said the arrangement is intended to give wealth clients access to customized co-investment opportunities in Japan.

Manulife executives framed the initiative as part of a broader effort to use the group's global investment capabilities through strategic partnerships. Liam Coppinger, head of private equity Asia at Manulife Investment Management, said the platform relies on established sponsor relationships and disciplined underwriting to identify opportunities and build diversified portfolios.

UBS executives pointed to a potentially more favorable Japanese buyout environment for skilled managers. Qingkun Guo, head of private equity Asia at UBS Unified Global Alternatives, cited rising deal flow from business successions, corporate carve-outs and take-private transactions as possible sources of opportunity.

Terms and earnings impact remain open

The announcement gives no programme size, investment timetable or transaction pipeline. That leaves the immediate contribution to Manulife's revenue and profit unclear. For shareholders, the initiative currently represents a strategic expansion of private-market distribution rather than a disclosed change to group financial guidance.

UBS said its Unified Global Alternatives business had combined invested assets of approximately 371 billion US dollars as of September 30, 2026. The figure describes the UBS platform and is not a commitment under the new programme.

Manulife stock traded at 39.94 euros on Lang & Schwarz at 16:30 CET on Thursday, November 12, 2026.

Manulife stock facts

  • Company: Manulife Financial Corporation
  • ISIN: CA56501R1064
  • Lang & Schwarz price: 39.94 euros on November 12, 2026, at 16:30 CET

Broader market developments can be followed in the S&P 500 market environment.

Investors will next look for the programme's eligibility rules, fees, investment terms and first transaction announcements. More news and analyses on Manulife stock.

Disclaimer...
en | CA56501R1064 | MFC | boerse | 70504909 | bgmi